Holding(s) in Company

Summary by AI BETAClose X

UBS Group AG, through UBS AG, has notified Renalytix PLC of a major holding, acquiring 7.086900% of the voting rights, totaling 30,971,077 shares, as of July 24, 2026. This acquisition represents a significant change from their previous notification, which indicated no holdings. The notification was made on July 27, 2026, and no financial instruments with similar economic effects were reported.

Disclaimer*

UK 100

Latest directors dealings